The anthropometric characteristics in the two groups were not significantly different.
|
|
- Anissa Adams
- 7 years ago
- Views:
Transcription
1 Studio prospettico, randomizzato monocentrico per il trattamento sintomatico dell insufficienza venosa cronica degli arti inferiori in pazienti trattati con calze preventive con filato SpikEnergy rispetto a pazienti trattati con calze preventive standard (Studio SEVI). A prospective, randomized, monocentric study on chronic venous insufficiency s symptoms treatment with compressive pantyhose with SpikEnergy yarn versus compressive standard stocking: the SEVI Study. INTRODUCTION Chronic venous insufficiency is a common disease that affects a huge part of the population (10-40% of adults), in particularly in female subgroup. Limb compression using graduate compressive socks and pantyhose is widely recommended as cardinal treatment of the symptoms of chronic venous insufficiency in cases of low-moderate insufficiency that are not candidate to surgery. SpikEnergy is a yarn made of copper, silicon and zinc that creates a low electromagnetic 300 microampere 4/10 nanotesla camp that as previously been tested in orthopaedic tutors with good results in terms of pain relieve and tolerability. The aim of this study is to evaluate the efficacy, easy of use and the results on venous insufficiency obtained whit a system consisting in 18 mmhg compressive pantyhose that contain SpikEnergy yarn when compared to common 18 mmhg compressive pantyhose that are usually prescribed in these kind of patients. METHODS The study was a prospective, randomized clinical trial performed in one single centre specialized in venous insufficiency evaluation and treatment. The study included 40 consecutive female patients who underwent clinical evaluation for venous insufficiency and that presented a superficial venous insufficiency classified as low-moderate, in absence of deep or superficial venous thrombosis or phlebostatic ulcers. Within 7 day from the screening visit, all the patients had to do a pregnancy test except for those already in menopause, and only those with negative test were enrolled.
2 At the first enrolment visit each patient was submitted to a complete physical examination that included the evaluation of oedema with the registration of ankle, calf and thigh circumference and the evaluation of venous insufficiency clinical signs such as varicose veins or the presence of teleangectasias. Anamnesis was performed, to evaluate inclusion and exclusion criteria, other comorbidities, the presence of allergies and the concomitant use of other medicines. Each patient was then submitted to ultrasonographic evaluation and to a series of questionnaires about the symptoms, using a numerical analogue scale (varying from 0 to 10) to evaluate pain, itch, burning and to assess the alteration of the quality of life concerning the venous insufficiency. Then an automatic computed randomization was performed; 20 patients received common pantyhose and were denominated Standard Group (ST), while the other 20 received pantyhose with SpikEnergy yarn and were denominated SpikEnergy Group (SP). The SpikEnergy pantyhoses were create cappello (Prof. Dotti?) su come hanno creato la calze, il campo elettromagnetico, I macchinari per la corretta calibratura di entrambi I modelli di calze. Both the groups were instructed to wear the system for at least 8 hours per day and to immediately contact the investigators in case of adverse events. At the 1 month (± 7 days) follow-up visit, each patient was submitted to the physical examination and to the symptoms questionnaires; moreover, a questionnaires regarding the tolerability, mobility and general satisfaction of the patient about her stocking system was compiled (possible assessments were excellent, good, satisfactory, poor or insufficient). At the 6 months (± 14 days) follow-up visits, each patient was submitted to the same kind of visit as the 1 month follow-up and was also submitted to ultrasonographic evaluation of the venous insufficiency level. Study enrolment started on May 12, 2011, the enrolment period was of 6 month, and the study ended on may 14, Inclusion criteria were: -age > 18 years -informed consent -patient C1-3, Ep,s, As,p, Pr, according to CEAP classification -patients able to wear compressive stocking system
3 Exclusion criteria were: -pregnancy -other classes of CEAP classification -use of phlebotonic drugs -limb arteriopathy -high risk of deep venous thrombosis -thrombophilic patients -hyperhomocysteinemia -allergy to the device s materials -neuropathy -cutaneous infection Primary end points were the reduction of oedema and the reduction of symptoms, in particularly pain, itch, burning and the improvement of quality of life, assessed with numeric analogue scales (NAS), and the eventual improvement of venous insufficiency evaluate with duplex scan. Secondary end points were the tolerability of the stocking system, the easy to use and mobility granted by the system and the general satisfaction of the patient. Statistical analysis was performed and data were presented as a distribution of continuous variables (mean, median, lower and higher value and standard deviation) and as frequency of categorical variables (absolute value and percentage); 95% confidence intervals were calculated. Frequencies were analysed with χ 2 testing or with exact Fisher s test, with t-test was used to evaluate normally distributed linear variables, or the Wilcoxon test. A p value < 0.05 has been considered statistically significant, and all the tests had two tails. RESULTS The study included an homogenous cohort of 40 female patients whose CEAP classification was C2,3, Ep, As, Pr. Three patients (7,5%) matched exclusion criteria of previous venous surgery but only for one leg while the other leg matched inclusion criteria, so it was considered a minor violation and the patients were included in the study.
4 The anthropometric characteristics in the two groups were not significantly different. Spikenergy (SP) Standard (ST) All Age (years) Mean Median 44.51( ) ( ) ( ) Height (cm) Mean Median ( ) ( ) ( ) Weight (kg) Mean Median 64 (48-88) 58 (45-104) 62 (45-104) BMI Mean Median ( ) ( ) ( ) As in general population, the percentage of patients with a family history of cardiovascular disease was high (30/40 patients, 75%), while other comorbidities were well distributed. Spikenergy (SP) Standard (ST) All Family History OF CVD 14 (70%) 16 (80%) 30 (75%) Smoking 2 (10%) 7 (35%) 9 (22.5%) Obesity 5 (25%) 6 (30%) 11 (27.5%) Dyslipidemia 5 (25%) 3 (15%) 8 (20%) Hypertension 1 (5%) 3 (15%) 4 (10%) CAD COPD Allergies 9 (45%) 8 (40%) 17 (42.5%) The pantyhose was correctly worn from all the patients during the entire study period, none of the patient stopped the study and all the patients regularly presented at the 1 month and 6 months follow-up visit. None adverse event was observed during the study. Thirty-eight patients (95%), presented at baseline visit with ankle oedema, so ranging C3 in CEAP classification. Comparing circumferences changes between baseline and 1 month follow-up, we observed a mean 0,20 cm reduction of ankle circumference in the SP group as well as in the ST group (t value 0, p ), a mean 0,23 cm reduction of calf circumference in the SP group versus an absence of variation in the ST group (t value , p ) and a
5 mean 0,33 cm reduction of thigh circumference in the SP group versus a mean 0,10 cm increase in the ST group (t value , p ). Comparing circumferences changes between baseline and 6 months follow-up, we observed a mean 0,40 cm reduction of ankle circumference in the SP group and a mean 0,30 cm reduction in the ST group (t value , p ), a mean 0,73 cm reduction of calf circumference in the SP group versus a mean 0,18 cm increase in the ST group (t value , p ) and a mean 0,63 cm reduction of thigh circumference in the SP group versus a mean 0,55 cm reduction in the ST group (t value , p ). Comparing symptoms, at 1 month pain reduced from a mean 3.40 to a mean 3.30 value in SP group and from a mean 5.2 to a mean 3.25 value in the ST group, itch increased from
6 a mean 1.70 to a mean 4.35 value in the SP group and reduced from a mean 2.05 to a mean 1.95 value in the ST group, burning reduced from a mean 2.40 to a mean 2.30 value in the SP group while it reduced from a mean 3.20 to a mean 1.35 mean value in the ST group. Concerning the assessment of quality of life improvements, we observed an increase from a mean 7.55 to a mean 7.75 value in the SP group and an increase form a mean 6.60 to a mean 8.40 value in the ST group. Comparing baseline and 6 month results, pain ad a mean 0.40 reduction in the SP group versus a mean 1.30 increase in the ST group (t value , p ), itch had a mean increase of 1.80 in the SP group versus a mean reduction of 0.05 in the ST group (t value 1.950, p ), burning had a mean 0.35 increase in the SP group and had a mean 1.05 reduction in the ST group (t value 1.332, p ), while quality of life had a mean 0.15 increase in the SP group versus a mean 1.55 increase in the ST group (t value , p ). Analyzing duplex scan findings at baseline, we observed that none of the patient presented with deep venous thrombosis, that was also an exclusion criteria; in most of the cases the venous insufficiency was due to saphenous-femoral ostium or internal
7 saphenous vein incompetence, only in 4 legs we observed saphenous-popliteal and external saphenous vein incompetence. At 6 month follow-up, in the SP group we observed incompetence worsening only in 1 case (only in one leg), passing from a normal continence to mild incompetence of the saphenous-femorale ostium; instead we observed worsening in 4 cases in the standard group: 1 passing from a normal continence to mild incompetence of the saphenousfemorale ostium (only in one leg), 1 passing from normal continence to mild incompetence of the internal saphenous vein (only in one leg), 1 passing from normal continence to mild incompetence of the saphenous-popliteal ostium (only in one leg) and 1 passing from from normal continence to mild incompetence of the external saphenous vein (only in one leg). None improvement in the ultrasonographic findings was observed in both the two groups. Comparing the tolerability, mobility granted by the device and the general satisfaction, the tolerability in the SP group was considered insufficient/poor in 4 cases, satisfactory in 9 cases and good/excellent in 7 cases at 1 month, while in the ST group it was assessed insufficient/poor in 0 case, satisfactory in 2 cases and good/excellent in 18 cases (p ). At 6 month the tolerability in the SP group was considered insufficient/poor in 4 cases, satisfactory in 10 cases and good/excellent in 6 cases, while in the ST group it was assessed insufficient/poor in 0 cases, satisfactory in 3 cases and good/excellent in 17 cases (p ). The mobility granted by the stocking in the SP group was considered insufficient/poor in 1 case, satisfactory in 7 cases and good/excellent in 12 cases at 1 month, while in the ST group it was assessed insufficient/poor in 1 case, satisfactory in 3 cases and good/excellent in 16 cases (p ). At 6 month the mobility in the SP group was considered insufficient/poor in 2 cases, satisfactory in 6 cases and good/excellent in 12 cases, while in the ST group it was assessed insufficient/poor in 1 case, satisfactory in 4 cases and good/excellent in 15 cases (p ). The general satisfaction in the SP group was considered insufficient/poor in 2 cases, satisfactory in 9 cases and good/excellent in 9 cases at 1 month, while in the ST group it was assessed insufficient/poor in 1 case, satisfactory in 1 case and good/excellent in 18 cases (p ). At 6 month the general satisfaction in the SP group was considered insufficient/poor in 3 cases, satisfactory in 8 cases and good/excellent in 9 cases, while in the ST group it was assessed insufficient/poor in 2 case, satisfactory in 3 cases and good/excellent in 15 cases (p ).
8 6 As collateral results, interviewing the patients we observed that those of SP group noticed an improvement in skin aspect and a slight reduction in cellulitis, suggesting a potential role of the electromagnetic camp on this aspect, that could be well investigated in the future. CONCLUSIONS The compressive pantyhose with SpikEnergy yarn seems to be safe; no adverse event was observed during the study not even in those that presented allergy to metals. Analyzing result, we observed a significant reduction of circumference at calf level in the SP group, in the other cases the differences were not statistically significant. Concerning on symptoms, a statistically significant reduction of pain in SP group was observed; however, a significant increase in itch was observed, and in some cases it was
9 evident that the itch was more due to the electromagnetic camp than to venous insufficiency (it disappeared at socks removal). Only slight and not statistically significant differences were observed in ultrasonographic findings, and is important to stress that none of the patient improved during the study, because obviously elastic compression treats the symptoms but can not improve venous valvular incompetence. The most significant information that emerges from the study is about the tolerability and the general satisfaction of the patient, that are significantly poorer in the SP group. Obviously the study is only on a small group of patients; future studies on larger group, eventually groups including also patient with phlebostatic ulcers or venous thrombosis could better understand the role of electromagnetic camp in venous insufficiency; probably it could be useful to test devices with a lower electromagnetic camp that can be more comfortable for the patients.
AMERICAN VENOUS FORUM
Revised Venous Clinical Severity Score AMERICAN VENOUS FORUM Pain : 0 Mild: 1 or other discomfort (ie, aching, heaviness, fatigue, soreness, burning) origin Occasional pain or other discomfort (ie, not
More informationBeaumont Hospital. Varicose Veins. and their TREATMENT. Professor Austin Leahy, MCh, FRCS, FRCSI WWW.VEINCLINICSOFIRELAND.COM
Beaumont Hospital Varicose Veins and their TREATMENT Professor Austin Leahy, MCh, FRCS, FRCSI WWW.VEINCLINICSOFIRELAND.COM Department of Surgery Beaumont Hospital and Royal College of Surgeons in Ireland
More informationPeninsula Commissioning Priorities Group. Commissioning Policy Varicose Vein Referral
NHS Devon NHS Plymouth Torbay Care Trust Peninsula Commissioning Priorities Group Commissioning Policy Varicose Vein Referral Varicose Vein Referral Guidelines 1. Description of service/treatment Most
More informationBaby Your Legs! Get relief for: Heavy, tired or aching legs Swollen ankles and feet Varicose or spider veins. Managing leg health during pregnancy
Baby Your Legs! Get relief for: Heavy, tired or aching legs Swollen ankles and feet Varicose or spider veins Managing leg health during pregnancy Common leg health problems during pregnancy Venous disorders
More informationTREATMENT OF VARICOSE VEINS: CAN IT BE IMPROVED BY MECHANOCHEMICAL ABLATION USING THE CLARIVEIN DEVICE?
TREATMENT OF VARICOSE VEINS: CAN IT BE IMPROVED BY MECHANOCHEMICAL ABLATION USING THE CLARIVEIN DEVICE? Michel MJP Reijnen Rijnstate Hospital, Arnhem The Netherlands mmpj.reijnen@gmail.com Disclosures
More informationMedicare C/D Medical Coverage Policy
Varicose Vein Treatment Origination Date: June 1, 1993 Review Date: July 20, 2016 Next Review: July, 2018 Medicare C/D Medical Coverage Policy DESCRIPTION OF PROCEDURE OR SERVICE Varicose veins of the
More informationLOWER EXTREMITY VENOUS DUPLEX ULTRASOUND:
LOWER EXTREMITY VENOUS DUPLEX ULTRASOUND: Chronic Venous Insufficiency Phillip J Bendick, PhD William Beaumont Hospital Royal Oak, Michigan Prevalence: Carotid ASO ~ 3M Peripheral Arterial Dz ~ 5M + CAD
More informationX-Plain Varicose Veins Reference Summary
X-Plain Varicose Veins Reference Summary Introduction Varicose veins are very common, in both women and men. Varicose veins can be painful and unattractive. Vein doctors use non-invasive ultrasound imaging
More informationConfirmed Deep Vein Thrombosis (DVT)
Confirmed Deep Vein Thrombosis (DVT) Information for patients What is deep vein thrombosis? Blood clotting provides us with essential protection against severe loss of blood from an injury to a vein or
More information1.0 Abstract. Title: Real Life Evaluation of Rheumatoid Arthritis in Canadians taking HUMIRA. Keywords. Rationale and Background:
1.0 Abstract Title: Real Life Evaluation of Rheumatoid Arthritis in Canadians taking HUMIRA Keywords Rationale and Background: This abbreviated clinical study report is based on a clinical surveillance
More informationPROVIDER POLICIES & PROCEDURES
PROVIDER POLICIES & PROCEDURES SCLEROTHERAPY TREATMENT OF SUPERFICIAL VARICOSE VEINS OF THE LEGS The purpose of this document is to provide guidance to providers enrolled in the Connecticut Medical Assistance
More informationTired, Aching Legs? Swollen Ankles? Varicose Veins? An informative guide for patients
Tired, Aching Legs? Swollen Ankles? Varicose Veins? An informative guide for patients Are You at Risk? Leg problems are widespread throughout the world, but what most people don t know is that approximately
More informationMedicare C/D Medical Coverage Policy
Varicose Vein Treatment Medicare C/D Medical Coverage Policy Origination Date: June 1, 1993 Review Date: September 16, 2015 Next Review: September, 2017 DESCRIPTION OF PROCEDURE OR SERVICE Varicose veins
More informationProvided by the American Venous Forum: veinforum.org
CHAPTER 17 SURGICAL THERAPY FOR DEEP VALVE INCOMPETENCE Original author: Seshadri Raju Abstracted by Gary W. Lemmon Introduction Deep vein valvular incompetence happens when the valves in the veins (tubes
More informationRecurrent Varicose Veins
Information for patients Recurrent Varicose Veins Sheffield Vascular Institute Northern General Hospital You have been diagnosed as having Varicose Veins that have recurred (come back). This leaflet explains
More informationSummary ID# 13614. Clinical Study Summary: Study F3Z-JE-PV06
CT Registry ID# Page 1 Summary ID# 13614 Clinical Study Summary: Study F3Z-JE-PV06 INSIGHTS; INSulin-changing study Intending to Gain patients insights into insulin treatment with patient-reported Health
More informationA Guide to Healthier Legs
A Guide to Healthier Legs Are You at Risk? Keeping Your Legs Healthy Leg problems are widespread throughout the world. According to the American College of Phlebology, more than 80 million Americans suffer
More informationSYNOPSIS. Risperidone: Clinical Study Report CR003274
SYNOPSIS Protocol No: CR003274 Title of Study: An Open-Label, Long-Term Trial of Risperidone Long-Acting Microspheres in the Treatment of Subjects Diagnosed with Schizophrenia Coordinating Investigator:
More informationNon-surgical treatment of severe varicose veins
Non-surgical treatment of severe varicose veins Yasu Harasaki UCHSC Department of Surgery General Surgery Grand Rounds March 19, 2007 Definition Dilated, palpable, subcutaneous veins generally >3mm in
More informationTREATMENT OF VARICOSE AND SPIDER VEINS Patient Info
TREATMENT OF VARICOSE AND SPIDER VEINS Patient Info www.heartofthevillages.com TIRED & ACHING LEGS? If you suffer from varicose and spider veins, you are not alone. It is estimated that there are more
More informationSCRIPT NUMBER 122 VARICOSE VEINS - 2 (TWO SPEAKERS)
SCRIPT NUMBER 122 VARICOSE VEINS - 2 (TWO SPEAKERS) PROGRAM NAME: HEALTH NUGGETS PROGRAM TITLE: VARICOSE VEINS - 2 PROGRAM NUMBER: 122 SUBJECT: SYMPTOMS, CAUSES, TREATMENT, PREVENTION OF VARICOSE VEINS
More informationClinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
More informationThis clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis which is part of the clinical
More informationtreatment of varicose and spider veins patient information SAMPLE a publication by advancing vein care
treatment of varicose and spider veins patient information a publication by advancing vein care Since most veins lie deep to the skin s surface, vein disorders are not always visible to the naked eye.
More informationTired legs, varicose veins
Tired legs, varicose veins Everything you need to know What are varicose veins? Varicose veins are swollen, enlarged and twisted veins in the deep or superficial venous system of the legs, due to loss
More informationA clinical trial designed to discover if the primary treatment of varicose veins should be by Fegan s method or by an operation
Br. J. Surg. Vol. 62 (1975) 72-76 A clinical trial designed to discover if the primary treatment of varicose veins should be by Fegan s method or by an operation F. S. A. DORAN AND MARY WHITE* SUMMARY
More informationGraduated compression hosiery (stockings)
What is compression hosiery? Compression hosiery are elasticated stockings which give support to your legs. In graduated compression hosiery, the pressure given by the stockings is greater at the ankle
More informationVaricose Veins Operation. Patient information Leaflet
Varicose Veins Operation Patient information Leaflet 22 nd August 2014 WHAT IS VARICOSE VEIN SURGERY (HIGH LIGATION AND MULTIPLE AVULSIONS) The operation varies from case to case, depending on where the
More information2.0 Synopsis. Vicodin CR (ABT-712) M05-765 Clinical Study Report R&D/07/095. (For National Authority Use Only) to Part of Dossier: Volume:
2.0 Synopsis Abbott Laboratories Name of Study Drug: Vicodin CR Name of Active Ingredient: Hydrocodone/Acetaminophen Extended Release (ABT-712) Individual Study Table Referring to Part of Dossier: Volume:
More informationLONG TERM FOLLOW-UP AFTER ENDOVENOUS LASER ABLATION
LONG TERM FOLLOW-UP AFTER ENDOVENOUS LASER ABLATION Giorgio Spreafico Centro Multidisciplinare Day Surgery Azienda Ospedaliera Università Padova - Italy Faculty Disclosure I have no financial relationships
More informationYes when meets criteria below
Vein Disease Treatment MP9241 Covered Service: Prior Authorization Required: Additional Information: Medicare Policy: BadgerCare Plus Policy: Yes when meets criteria below Yes None Dean Health Plan covers
More informationInformation for patients who require Foam Sclerotherapy for Varicose Veins.
Information for patients who require Foam Sclerotherapy for Varicose Veins. Why do I need this procedure? Everybody has two sets of veins in the legs. These include the superficial and deep veins. Their
More informationMEDICAL COVERAGE POLICY. SERVICE: Varicose Veins of the Lower Extremities. PRIOR AUTHORIZATION: Required.
Page 1 of 5 MEDICAL COVERAGE POLICY Important note Even though this policy may indicate that a particular service or supply may be considered covered, this conclusion is not based upon the terms of your
More informationOutcome of Drug Counseling of Outpatients in Chronic Obstructive Pulmonary Disease Clinic at Thawangpha Hospital
Mahidol University Journal of Pharmaceutical Sciences 008; 35(14): 81. Original Article Outcome of Drug Counseling of Outpatients in Chronic Obstructive Pulmonary Disease Clinic at Thawangpha Hospital
More informationUniversity of Huddersfield Repository
University of Huddersfield Repository Atkin, Leanne and Shirlow, K. Understanding and applying compression therapy Original Citation Atkin, Leanne and Shirlow, K. (2014) Understanding and applying compression
More informationRapid Critical Appraisal of Controlled Trials
Rapid Critical Appraisal of Controlled Trials Carl Heneghan Dept of Primary Health Care University of Oxford November 23rd 2009 Five steps in EBM 1. Formulate an answerable question 2. Track down the best
More informationFURTHER EXPERIENCE WITH SUBCUTANEOUS IMMUNOGLOBULIN THERAPY IN CHILDREN WITH PRIMARY IMMUNE DEFICIENCIES
FURTHER EXPERIENCE WITH SUBCUTANEOUS IMMUNOGLOBULIN THERAPY IN CHILDREN WITH PRIMARY IMMUNE DEFICIENCIES Dr Alison Jones Great Ormond Street Hospital for Children NHS Trust London WC1N 3JH United Kingdom
More informationVenous Reflux Disease and Current Treatments VN20-87-A 01/06
Venous Reflux Disease and Current Treatments Leg Vein Anatomy Your legs are made up of a network of veins and vessels that carry blood back to the heart The venous system is comprised of: Deep veins Veins
More informationMedical Coverage Policy Treatment for Varicose Veins-PREAUTH
Medical Coverage Policy Treatment for Varicose Veins-PREAUTH Device/Equipment Drug Medical Surgery Test Other Effective Date: 9/1/2001 Policy Last Updated: 12/20/2011 Prospective review is recommended/required.
More informationThis clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis which is part of the clinical
More informationEndovenous Laser Therapy
Information for patients Endovenous Laser Therapy Northern General Hospital You have been given this leaflet because you will be having Endovenous Laser Therapy (EVLT). This leaflet explains more about
More informationCol league. SMMC Vascular Center Opens A PUBLICATION FOR SOUTHERN MAINE PHYSICIANS
A PUBLICATION FOR SOUTHERN MAINE PHYSICIANS Col league 8 2012 SMMC Vascular Center Opens By Frank Lavoie, MD, Executive Vice President and Chief Operating Officer During the last year, Southern Maine Medical
More informationLASER TREATMENT FOR VARICOSE VEINS
LASER TREATMENT FOR VARICOSE VEINS How can varicose veins be treated by laser? Laser treatment of varicose veins, Endovascular Laser Ablation (known as EVLA), is a minimally invasive procedure for treating
More informationRe: LUMIGAN 0.03% (bimatoprost ophthalmic solution 0.03%) and LUMIGAN 0.01% (bimatoprost ophthalmic solution 0.01%)
Allergan Ltd, 1st Floor, Marlow International, Parkway, Marlow, Bucks SL7 1YL Tel: (01628) 494444 Facsimile: (01628) 494449 Ref No: UK15-000677 Mandeep Allingham NW Surrey CCG February 18, 2015 Dear Ms
More informationThe veins of the lower limbs can be subdivided into three subtypes: deep veins, superficial veins, and connecting veins (figure 1).
VEIN DISEASE Vein disease may seem insignificant and harmless at first, but if left untreated, it can develop into a major problem. It occurs when veins have trouble transporting blood back to the heart
More informationVaricose veins and spider veins
Varicose veins and spider veins Summary Varicose veins are knobbly, twisted and darkish-blue in appearance, and are most commonly found on people s legs. Varicose veins are caused by faulty valves within
More informationTired, Aching Legs? Swollen Ankles? Varicose Veins?
Tired, Aching Legs? Swollen Ankles? Varicose Veins? Healthy Legs 2006 http://healthylegs.com Page 1 Venous disorders are widespread Leg problems are widespread throughout the world, but what most people
More informationProvided by the American Venous Forum: veinforum.org
CHAPTER 1 NORMAL VENOUS CIRCULATION Original author: Frank Padberg Abstracted by Teresa L.Carman Introduction The circulatory system is responsible for circulating (moving) blood throughout the body. The
More informationSurgical Options for Venous Disease. Sandra C Carr MD Vascular Surgery Meriter Wisconsin Heart
Surgical Options for Venous Disease Sandra C Carr MD Vascular Surgery Meriter Wisconsin Heart Chronic Venous Disease Approximately 23% of adults in the US have varicose veins Estimated 22 million women
More informationCHAPTER 15 SCLEROTHERAPY FOR VENOUS DISEASE
Introduction CHAPTER 15 SCLEROTHERAPY FOR VENOUS DISEASE Original authors: Niren Angle, John J. Bergan, Joshua I. Greenberg, and J. Leonel Villavicencio Abstracted by Teresa L. Carman New technology has
More informationVaricose Veins and Spider Veins
page 1 Varicose Veins and Spider Veins Q: What are varicose veins and spider A: Varicose (VAR-i-kos) veins are enlarged veins that can be blue, red, or fleshcolored. They often look like cords and appear
More informationEndoVenous Laser Therapy (EVLT) Information Booklet. Dr. Dueck. Varicose Veins
EndoVenous Laser Therapy (EVLT) Information Booklet Dr. Dueck Varicose Veins Varicose veins are abnormally large veins that protrude from under the skin in the legs. They can be associated with a brown
More informationInformation for you Treatment of venous thrombosis in pregnancy and after birth. What are the symptoms of a DVT during pregnancy?
Information for you Treatment of venous thrombosis in pregnancy and after birth Published in September 2011 What is venous thrombosis? Thrombosis is a blood clot in a blood vessel (a vein or an artery).
More informationWhat are spider veins? What is the best treatment for spider veins?
Laser Spider/Leg Vein Q & A What are spider veins? Millions of women and men are bothered by unsightly spider veins on their faces and legs. Spider veins or telangiectasias are those small red, blue and
More informationFemoral artery bypass graft (Including femoral crossover graft)
Femoral artery bypass graft (Including femoral crossover graft) Why do I need the operation? You have a blockage or narrowing of the arteries supplying blood to your leg. This reduces the blood flow to
More informationRecurrent Varicose Veins. Vineet Mishra, MD Director of Mohs Surgery and Procedural Dermatology University of Texas Health Science Center San Antonio
Recurrent Varicose Veins Vineet Mishra, MD Director of Mohs Surgery and Procedural Dermatology University of Texas Health Science Center San Antonio Disclosures None Possible Causes of Recurrence DNA:
More informationA Phase 2 Study of Interferon Beta-1a (Avonex ) in Ulcerative Colitis
A Phase 2 Study of (Avonex ) in Ulcerative Colitis - Study Results - ClinicalTrials.gov A Phase 2 Study of (Avonex ) in Ulcerative Colitis This study has been completed. Sponsor: Biogen Idec Information
More informationT.E.D. Anti-Embolism Stockings
T.E.D. Anti-Embolism Stockings You have been given this information because you are spending time in the hospital. This booklet contains important information about why you are wearing T.E.D. anti-embolism
More informationRenovascular Hypertension
Renovascular Hypertension Philip Stockwell, MD Assistant Professor of Medicine (Clinical) Warren Alpert School of Medicine Cardiology for the Primary Care Provider September 28, 201 Renovascular Hypertension
More informationHumulin (LY041001) Page 1 of 1
(LY041001) These clinical study results are supplied for informational purposes only in the interests of scientific disclosure. They are not intended to substitute for the FDA-approved package insert or
More informationVaricose Vein Surgery Criteria Access Based Protocol Supporting people in Dorset to lead healthier lives
NHS Dorset Clinical Commissioning Group Varicose Vein Surgery Criteria Access Based Protocol Supporting people in Dorset to lead healthier lives NHS DORSET CLINICAL COMMISSIONING GROUP VARICOSE VEIN SUREGRY
More informationTo provide standardized Supervised Exercise Programs across the province.
TITLE ALBERTA HEALTHY LIVING PROGRAM SUPERVISED EXERCISE PROGRAM DOCUMENT # HCS-67-01 APPROVAL LEVEL Executive Director Primary Health Care SPONSOR Senior Consultant Central Zone, Primary Health Care CATEGORY
More informationPRACTICE PROBLEMS FOR BIOSTATISTICS
PRACTICE PROBLEMS FOR BIOSTATISTICS BIOSTATISTICS DESCRIBING DATA, THE NORMAL DISTRIBUTION 1. The duration of time from first exposure to HIV infection to AIDS diagnosis is called the incubation period.
More informationClinical Medical Policy Varicose Vein Treatment
Benefit Coverage Covered Benefit for lines of business including: Health Benefits Exchange (HBE), Rite Care (MED), Children with Special Needs (CSN), Substitute Care (SUB), Rhody Health Partners (RHP),
More informationTHE RELATIONSHIP BETWEEN PATIENT STATUS AND RECURRENCY RATE FOLLOWING LASER SURGERY OF VARICOSE VEINS
THE RELATIONSHIP BETWEEN PATIENT STATUS AND RECURRENCY RATE FOLLOWING LASER SURGERY OF VARICOSE VEINS Dr Imre Bihari PhD Budapest, Hungary What can influence laser surgery results? Instrument and method
More informationCardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg
Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg 2 nd Annual Duke Renal Transplant Symposium March 1, 2014 Durham, NC Joseph G. Rogers, M.D. Associate
More informationPreventing Blood Clots in Adult Patients. Information For Patients
Preventing Blood Clots in Adult Patients Information For Patients 1 This leaflet will give you information on how to reduce the risk of developing blood clots during and after your stay in hospital. If
More informationSponsor Novartis Pharmaceuticals
Clinical Trial Results Database Page 1 Sponsor Novartis Pharmaceuticals Generic Drug Name Indacaterol Therapeutic Area of Trial Chronic Obstructive Pulmonary Disease (COPD) Indication studied: COPD Study
More informationSEDICO Newsletter Issue 8. Varicose veins
SEDICO Newsletter Issue 8 Definition: Varicose veins Varicose veins are veins that have become enlarged and twisted. The term commonly refers to the veins on the leg, although varicose veins occur elsewhere.
More informationVARICOSE VEINS. Information Leaflet. Your Health. Our Priority. VTE Ambulatory Clinic Stepping Hill Hospital
VARICOSE VEINS Information Leaflet Your Health. Our Priority. Page 2 of 7 Varicose Veins There are no accurate figures for the number of people with varicose veins. Some studies suggest that 3 in 100 people
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal. Drugs for the treatment of pulmonary arterial hypertension
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal Drugs for the treatment of Remit / Appraisal objective: Final scope To appraise the clinical and cost effectiveness of
More informationUnderstanding Varicose Veins
Understanding Varicose Veins Professor Bruce Campbell Published by Family Doctor Publications Limited in association with the British Medical Association IMPORTANT NOTICE This book is intended not as a
More informationDonor Adverse Events
Donor Adverse Events Common terminology Frequency Risk factors Hold still, Mrs. Brown, while I draw your blood Mindy Goldman, MD Canadian Blood Services IHN Seminar, Paris March 11, 2016 Outline Donor
More informationV03 Varicose Veins Surgery
V03 Varicose Veins Surgery What are varicose veins? Varicose veins are enlarged and twisted veins in the leg. They are common and affect up to 3 in 10 people. More women than men ask for treatment, with
More informationDeep Vein Thrombosis (DVT) in pregnancy
Deep Vein Thrombosis (DVT) in pregnancy Information and advice for women and families Maternity What is a deep vein thrombosis (DVT)? A deep vein thrombosis (DVT) is a blood clot that forms in a deep leg
More informationTreatment by LASER. Understanding Varicose veins and. Dr. Rajesh Mundhada (MD. DNB) Dr. Atul Rewatkar (MD)
Understanding Varicose veins and Treatment by LASER Dr. Rajesh Mundhada (MD. DNB) Dr. Atul Rewatkar (MD) Orange city Hospital & Research Institute 19, Pandey Lay out, Veer Sawarkar Square, Nagpur 440015
More informationY O U R S U R G E O N S. choice of. implants F O R Y O U R S U R G E R Y
Y O U R S U R G E O N S choice of implants F O R Y O U R S U R G E R Y Y O U R S U R G E O N S choice of implants F O R Y O U R S U R G E R Y Your Surgeon Has Chosen the C 2 a-taper Acetabular System The
More informationVaricose Veins: Causes, Symptoms and Management. Andrew C. Stanley MD Section of Vascular Surgery
Varicose Veins: Causes, Symptoms and Management Andrew C. Stanley MD Section of Vascular Surgery Circulation Heart (Pump)-MI, Sudden Death Arteries (Stroke, Aneurysms, Walking dysfunction, Limb loss) Veins
More informationThe Treatment of Varicose Veins and Spider Veins
The Treatment of Varicose Veins and Spider Veins St. Joseph Vein Center Surgical Specialists of St. Joseph, P.C. Glen H. Hastings, M.D., F.A.C.S. 820 Lester Ave., Suite 105 St. Joseph, MI 49085 (269) 983-3368
More informationMINISTERIO DE SALUD PUBLICA DIRECCION PROVINCIAL DE SALUD DEL GUAYAS HOSPITAL DE INFECTOLOGIA DR. JOSE DANIEL RODRIGUEZ MARIDUEÑA Guayaquil - Ecuador
EVALUATION OF THE EFFECTIVENESS OF THE PRODUCT BABUNA IN THE TREATMENT OF INSOMNIA, IN PATIENTS OF THE MALE WING OF THE ECUADORIAN HEALTH MINISTRY S HOSPITAL OF INFECTIOUS DISEASE PILLASAGUA Diana, ANDINO
More informationMeasure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care
Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY
More informationParametric and non-parametric statistical methods for the life sciences - Session I
Why nonparametric methods What test to use? Rank Tests Parametric and non-parametric statistical methods for the life sciences - Session I Liesbeth Bruckers Geert Molenberghs Interuniversity Institute
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)
London, 22 October 2009 Doc. Ref. EMEA/CHMP/EWP/692702/2008 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) REFLECTION PAPER ON THE EXTRAPOLATION OF RESULTS FROM CLINICAL STUDIES CONDUCTED OUTSIDE
More informationAll patients presenting to the Emergency Department with symptoms suggestive of
APPENDIX: Online Data Supplements Clinical Trial Inclusion and Exclusion Criteria All patients presenting to the Emergency Department with symptoms suggestive of acute coronary syndrome (ACS) were screened
More informationClinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
More informationESC Guidelines on the diagnosis and treatment of peripheral artery diseases Lower extremity artery disease. Erich Minar Medical University Vienna
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Lower extremity artery disease Erich Minar Medical University Vienna for the Task Force on the Diagnosis and Treatment of Peripheral
More informationVenefit treatment for varicose veins
Oxford University Hospitals NHS Trust Venefit treatment for varicose veins Information for patients Your consultant has recommended that we treat your varicose veins with a procedure known as Venefit radio
More informationMEDICAL COVERAGE POLICY SERVICE: Varicose Veins of the Lower Extremities. SERVICE: Treatment of Varicose Veins of the Lower Extremities
Important note Even though this policy may indicate that a particular service or supply may be considered covered, this conclusion is not based upon the terms of your particular benefit plan. Each benefit
More informationManagement of exacerbations in chronic obstructive pulmonary disease in Primary Care
Management of exacerbations in chronic obstructive pulmonary disease in Primary Care Acute exacerbations of chronic obstructive pulmonary disease (COPD) are associated with significant morbidity and mortality.
More informationCMS Limitations Guide - Radiology Services
CMS Limitations Guide - Radiology Services Starting October 1, 2015, CMS will update their existing medical necessity limitations on tests and procedures to correspond to ICD-10 codes. This limitations
More informationMarc A. Cohen, MD, FAAOS, FACS Diplomate American Board of Spinal Surgery Fellow American College of Spinal Surgery
Marc A. Cohen, MD, FAAOS, FACS Diplomate American Board of Spinal Surgery Fellow American College of Spinal Surgery 221 Madison Ave Morristown, New Jersey 07960 (973) 538 4444 Fax (973) 538 0420 Patient
More informationFREEDOM C: A 16-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C
FREEDOM C: A 16-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C SR in Combination with an ERA and/or a PDE-5 Inhibitor
More informationMeasure #420: Varicose Vein Treatment with Saphenous Ablation: Outcome Survey National Quality Strategy Domain: Effective Clinical Care
Measure #420: Varicose Vein Treatment with Saphenous Ablation: Outcome Survey National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION:
More informationDo you have any of these varicose vein symptoms?
Do you have any of these varicose vein symptoms? Heaviness Achiness Swelling Throbbing Itching HASTI Symptoms Ask your doctor if Varithena is right for you Varithena (polidocanol injectable foam) is a
More informationTitle Use of rivaroxaban in suspected DVT in the Emergency Department Standard Operating Procedure. Author s job title. Pharmacist.
Document Control Title Use of rivaroxaban in suspected DVT in the Emergency Department Author Pharmacist Directorate Clinical Support Services Version Date Issued Status 0.1 Oct Draft 2015 1.0 Dec Final
More informationThe challenge of herpes
The challenge of herpes Herpes is a common and personally challenging disease Herpes is very common. One out of four adults has genital herpes. When people first hear that they are infected, many become
More informationPsoriasis, Incidence, Quality of Life, Psoriatic Arthritis, Prevalence
1.0 Abstract Title Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients with Psoriasis Severe or Moderate with Adalimumab Treatment (TOGETHER). Keywords Psoriasis,
More informationDEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource
E-Resource March, 2015 DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource Depression affects approximately 20% of the general population
More informationAtrial Fibrillation The Basics
Atrial Fibrillation The Basics Family Practice Symposium Tim McAveney, M.D. 10/23/09 Objectives Review the fundamentals of managing afib Discuss the risks for stroke and the indications for anticoagulation
More informationVenous thromboembolism: reducing the risk. Quick reference guide. Issue date: January 2010
Issue date: January 2010 Venous thromboembolism: reducing the risk Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital This guideline
More information